Outside of alleviating premature onset of atherosclerosis associated with genetic deficiency in LAL, it is hard to predict whether augmentation of LAL is a good therapeutic strategy. This evidence concerns the gene LIPA and hyperinsulinemic hypoglycemia, familial, 4.